Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China · Delayed Price · Currency is CNY 4.050
-0.070 (-1.70%)
Apr 30, 2026, 3:00 PM CST
SHA:600594 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -355.48 | -335.34 | -317.22 | 103.4 | -426.39 | 243.77 |
Depreciation & Amortization | 171.3 | 171.3 | 192.69 | 201.11 | 181.48 | 149.94 |
Other Amortization | 21.89 | 21.89 | 34.34 | 28.16 | 46.9 | 53.24 |
Loss (Gain) From Sale of Assets | 27.21 | 27.21 | -0.78 | -0.02 | -31.05 | 1.37 |
Asset Writedown & Restructuring Costs | 163.44 | 163.44 | 58.02 | 19.93 | 627.43 | 142.19 |
Loss (Gain) From Sale of Investments | 0.21 | 0.21 | -0.34 | -0.03 | -1.83 | -34.64 |
Provision & Write-off of Bad Debts | - | - | -5.04 | -3.19 | -0.27 | 7.43 |
Other Operating Activities | 94.11 | 36.32 | 42.02 | 104.2 | 49.38 | 72.84 |
Change in Accounts Receivable | 145.72 | 145.72 | 184.28 | 44.61 | 69.38 | 241.25 |
Change in Inventory | 76.68 | 76.68 | 41.75 | -26.6 | -88.41 | -87.09 |
Change in Accounts Payable | -60.46 | -60.46 | -105.38 | -88.77 | -57.63 | 137.14 |
Operating Cash Flow | 294.36 | 256.71 | 86.87 | 377.61 | 345.3 | 934.21 |
Operating Cash Flow Growth | - | 195.50% | -76.99% | 9.36% | -63.04% | 154.79% |
Capital Expenditures | -35.92 | -34.99 | -96.32 | -130.38 | -322.92 | -447.78 |
Sale of Property, Plant & Equipment | 7.59 | 6.9 | 1.17 | 0.09 | 4.78 | 6.63 |
Cash Acquisitions | - | - | - | - | - | -332.04 |
Divestitures | - | - | - | - | - | -18.56 |
Investment in Securities | - | - | -19.99 | - | -20 | 100.71 |
Other Investing Activities | 0.2 | 0.08 | 11.3 | 14.7 | 30.37 | 3.37 |
Investing Cash Flow | -28.13 | -28 | -103.84 | -115.59 | -307.78 | -687.67 |
Long-Term Debt Issued | - | 516 | 560 | 741.33 | 895.7 | 1,095 |
Long-Term Debt Repaid | - | -754.8 | -607.83 | -850.84 | -743.72 | -1,393 |
Net Debt Issued (Repaid) | -172.1 | -238.8 | -47.83 | -109.51 | 151.98 | -297.81 |
Repurchase of Common Stock | - | - | -25 | - | - | - |
Common Dividends Paid | -26.21 | -28.69 | -86.87 | -41.18 | -49.11 | -152.12 |
Other Financing Activities | -35.08 | -35.08 | - | -1 | 66 | -35.08 |
Financing Cash Flow | -233.39 | -302.57 | -159.71 | -151.69 | 168.87 | -485.01 |
Foreign Exchange Rate Adjustments | -0.02 | -0.01 | -0 | - | - | - |
Net Cash Flow | 32.82 | -73.87 | -176.67 | 110.33 | 206.39 | -238.47 |
Free Cash Flow | 258.44 | 221.71 | -9.45 | 247.23 | 22.38 | 486.43 |
Free Cash Flow Growth | - | - | - | 1004.93% | -95.40% | - |
Free Cash Flow Margin | 15.02% | 11.90% | -0.43% | 8.77% | 0.82% | 14.54% |
Free Cash Flow Per Share | 0.33 | 0.28 | -0.01 | 0.31 | 0.03 | 0.61 |
Cash Income Tax Paid | 154.43 | 162.35 | 193.74 | 318.26 | 304.93 | 379.86 |
Levered Free Cash Flow | 357.49 | 283.51 | 89.93 | 150.26 | -107.51 | 288.92 |
Unlevered Free Cash Flow | 357.49 | 283.51 | 106.42 | 163.78 | -84.09 | 310.88 |
Change in Working Capital | 171.67 | 171.67 | 83.19 | -75.95 | -100.34 | 298.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.